Abstract
Inherited thrombophilia is defined as a genetically determined tendency to develop venous thromboembolism. In children, inherited thrombophilia contributes to the development of pediatric thromboembolic disease. As a consequence, pediatric hematologists are increasingly requested to test thrombophilia in pediatric patients with thrombosis or asymptomatic children from thrombophilic families. This article reviews the benefits and limitations of testing for thrombophilic disorders, for example, factor V Leiden, prothrombin mutation, and deficiencies of antithrombin, protein C, or protein S in childhood.
© Thieme Medical Publishers.
MeSH terms
-
Adolescent
-
Adult
-
Anticoagulants / economics
-
Antithrombin III / genetics
-
Antithrombin III Deficiency / diagnosis
-
Antithrombin III Deficiency / epidemiology
-
Child
-
Diagnostic Tests, Routine / economics
-
Factor V / genetics
-
False Positive Reactions
-
Female
-
Humans
-
Mutation
-
Pregnancy
-
Prevalence
-
Protein C / genetics
-
Protein C Deficiency / diagnosis
-
Protein C Deficiency / epidemiology
-
Protein S / genetics
-
Protein S Deficiency / diagnosis
-
Protein S Deficiency / epidemiology
-
Prothrombin / genetics
-
Recurrence
-
Thrombophilia / diagnosis
-
Thrombophilia / genetics*
Substances
-
Anticoagulants
-
Protein C
-
Protein S
-
factor V Leiden
-
Antithrombin III
-
Factor V
-
Prothrombin